Medicine Man Technologies (Schwazze) Enters Restructuring Deal with Vireo, Plans Major Asset Sale and Liquidation of Remaining Operations
Medicine Man Technologies Inc., operating as Schwazze, has entered into a Restructuring Support Agreement (RSA) with an affiliate of Vireo Growth Inc. and other stakeholders. Under the RSA, the company plans to sell a majority of its assets to a newly formed entity, NewCo, which will be majority-owned by Vireo. Following the asset sale, the remaining operations of the company will be liquidated and wound down. The credit bid for the asset sale will be submitted by the collateral agent for the senior secured notes, and, if successful, NewCo will assume certain liabilities and discharge most of the senior secured notes. NewCo is set to receive up to $62 million in financing to support the transaction, refinance specific debts, and provide working capital. Remaining company assets not included in the sale will be liquidated, with proceeds distributed according to legal priorities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicine Man Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-099048), on October 14, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。